Roche
-
Roche plans to invest $50 billion in the United States over the next five years
Apr 23, 2025Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five years. “These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R&D... -
Roche is not planning job cuts and its business is healthy, CEO Thomas Schinecker said
Dec 30, 2024Swiss pharmaceutical company Roche is not planning job cuts and its business is healthy, CEO Thomas Schinecker was quoted as saying by a Swiss newspaper on Sunday. Roche’s share price has fallen far below peaks it... -
Roche to pay $7.1 bn for Telavant Holdings
Oct 24, 2023On Monday, the Swiss pharmaceutical company Roche announced that it will acquire Telavant Holdings, a company that is creating novel treatments for inflammatory bowel disorders, for $7.1 billion. Currently, American pharmaceutical behemoth Pfizer and British laboratory... -
Roche gets US FDA approval for COVID-19 vs. flu test
Sep 4, 2020Drugmaker Roche had got Emergency Use Authorization from the U.S. Food and Drug Administration for a trial to rapidly detect whether a patient has SARS-CoV-2 or one of two forms of influenza, the company said today.... -
Roche to pay $2.4 billion to buy the rest of Foundation Medicine
Jun 19, 2018Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine (FMI), raising its bet on the U.S. genomic profiling group’s ability to personalize cancer care. The deal, backed by the boards of... -
EU panel recommended approval of Roche’s Hemlibra to treat hemophilia
Jan 28, 2018The EU’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Hemlibra for routine prophylaxis of bleeding in people with hemophilia A who have developed resistance to standard treatments. A European Union... -
Roche breast cancer drug at the center of a prolonged pricing row in Britain to be paid for routinely
Jun 16, 2017News Hour: A Roche breast cancer drug at the center of a prolonged pricing row in Britain will now be paid for routinely, following a discount deal between the company and the National Health Service (NHS).... -
Roche’s Alecensa kept people with lung cancer alive longer than Pfizer’s Xalkori
Apr 10, 2017News Hour: Roche’s Alecensa kept people with a specific lung cancer alive longer without their disease progressing than Pfizer’s Xalkori, the Swiss drugmaker said on Monday, as it seeks to move in on the U.S. company’s... -
Roche said, it remains committed to diabetes care business following a report it may exit
Feb 1, 2017News Hour: Swiss drugmaker Roche said on Wednesday it remains committed to its diabetes care business following a report that the company was considering options for the unit. There has been “no change”, said a Roche... -
FDA granted priority review designation of Roche’s Actemra
Jan 25, 2017News Hour: The U.S. Food and Drug Administration (FDA) has granted priority review designation of Roche’s rheumatoid arthritis medication Actemra for giant cell arteritis (GCA), the Swiss drugmaker said on Tuesday. “We will continue to work...
